Literature DB >> 6349454

Reactive hypoglycemia and insulin autoantibodies in drug-induced lupus erythematosus.

P J Blackshear, H E Rotner, K A Kriauciunas, C R Kahn.   

Abstract

An 82-year-old woman developed symptomatic reactive hypoglycemia in the same year she developed a lupus-like syndrome, probably secondary to the administration of procainamide or hydralazine. Reactive hypoglycemia was confirmed by an oral glucose tolerance test, in which plasma glucose decreased from a fasting level of 87 mg/dL to 32 mg/dL at 3 hours and 23 mg/dL at 4 hours, the last value being associated with loss of consciousness. The patient awoke after the intravenous administration of dextrose. Sensitivity to exogenous insulin was normal or increased. Attempts to measure plasma insulin levels led to the finding of anti-insulin antibodies in the patient's serum; these antibodies were of relatively low titer, were IgG, and not associated with antibodies to the insulin receptor. The patient had no history of exogenous insulin use. Her reactive hypoglycemia appeared due to the autoimmune insulin syndrome, which developed in association with drug-induced lupus erythematosus.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6349454     DOI: 10.7326/0003-4819-99-2-182

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  11 in total

Review 1.  Antigen-specific responses in autoimmunity and tolerance.

Authors:  J W Thomas
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  Lack of anti-insulin, anti-GAD, and anti-IA2 autoantibodies in primary antiphospholipid syndrome.

Authors:  Jozélio Freire de Carvalho; Maria Teresa Correia Caleiro
Journal:  Rheumatol Int       Date:  2011-03-26       Impact factor: 2.631

3.  NFATc2 (NFAT1) assists BCR-mediated anergy in anti-insulin B cells.

Authors:  Rachel H Bonami; William T Wolfle; James W Thomas; Peggy L Kendall
Journal:  Mol Immunol       Date:  2014-02-06       Impact factor: 4.407

Review 4.  Drug-induced hypoglycaemia: an update.

Authors:  Chaker Ben Salem; Neila Fathallah; Houssem Hmouda; Kamel Bouraoui
Journal:  Drug Saf       Date:  2011-01-01       Impact factor: 5.606

5.  Clinical and biochemical aspects of the insulin autoimmune syndrome (IAIS).

Authors:  G Trenn; V Eysselein; H U Mellinghoff; R Müller; G Benker; D Reinwein; K Federlin
Journal:  Klin Wochenschr       Date:  1986-10-01

6.  Insulin antibodies and hypoglycemia in diabetic patients. Can a quantitative analysis of antibody binding predict the risk of hypoglycemia?

Authors:  M R Kim; L R Sheeler; N Mansharamani; M T Haug; C Faiman; M K Gupta
Journal:  Endocrine       Date:  1997-06       Impact factor: 3.633

7.  The determination of detection limits for insulin antibody assays.

Authors:  A B Kurtz; L DiSilvio; E Bosi
Journal:  Diabetologia       Date:  1988-06       Impact factor: 10.122

8.  Influence of affinity of antibodies upon their detection by liquid phase radiobinding assay and solid phase enzyme linked immunosorbent assay. Demonstration using monoclonal antibodies raised against rDNA human proinsulin.

Authors:  J C Sodoyez; M Koch; I Lemaire; F Sodoyez-Goffaux; A Rapaille; C François-Gérard; D Sondag
Journal:  Diabetologia       Date:  1991-07       Impact factor: 10.122

9.  Characterization of insulin autoantibodies in a patient with autoimmune hypoglycemia.

Authors:  A Di Cerbo; V Tassi; A Scillitani; G Zoppetti; V De Filippis
Journal:  J Endocrinol Invest       Date:  1995-04       Impact factor: 4.256

10.  Recurrent hypoglycemia from insulin autoimmune syndrome.

Authors:  Sophia L Wong; Anne Priestman; Daniel T Holmes
Journal:  J Gen Intern Med       Date:  2013-08-24       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.